🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/07/2012 | 11,29 | 11,32 | 11,13 | 11,21 | -0,22% | 1,71% | 104.676 |
| 12/07/2012 | 11,05 | 11,29 | 10,74 | 11,24 | +0,78% | 4,97% | 185.627 |
| 11/07/2012 | 11,15 | 11,18 | 10,89 | 11,15 | -0,06% | 2,63% | 278.922 |
| 10/07/2012 | 11,06 | 11,17 | 11,04 | 11,15 | +0,90% | 1,13% | 302.646 |
| 09/07/2012 | 10,82 | 11,09 | 10,68 | 11,05 | +2,19% | 3,81% | 177.612 |
| 06/07/2012 | 10,66 | 10,91 | 10,63 | 10,82 | +0,23% | 2,63% | 116.378 |
| 05/07/2012 | 10,84 | 10,90 | 10,61 | 10,79 | -0,40% | 2,76% | 192.841 |
| 03/07/2012 | 10,64 | 10,84 | 10,56 | 10,84 | +1,58% | 2,64% | 233.237 |
| 02/07/2012 | 10,56 | 10,74 | 10,42 | 10,67 | +0,94% | 3,07% | 280.365 |
| 29/06/2012 | 10,35 | 10,63 | 10,24 | 10,57 | +3,74% | 3,74% | 302.005 |
| 28/06/2012 | 9,90 | 10,29 | 9,70 | 10,19 | +4,55% | 5,92% | 365.324 |
| 27/06/2012 | 9,51 | 9,94 | 9,51 | 9,74 | +2,43% | 4,46% | 240.931 |
| 26/06/2012 | 9,46 | 9,61 | 9,30 | 9,51 | -0,46% | 3,36% | 266.098 |
| 25/06/2012 | 9,94 | 9,94 | 9,49 | 9,56 | -4,67% | 4,46% | 208.069 |
| 22/06/2012 | 10,29 | 10,34 | 9,53 | 10,03 | -2,55% | 7,88% | 975.746 |
| 21/06/2012 | 9,64 | 10,77 | 9,55 | 10,29 | +13,33% | 12,68% | 2.310.244 |
| 20/06/2012 | 8,07 | 9,08 | 7,96 | 9,08 | +12,79% | 13,92% | 614.911 |
| 19/06/2012 | 7,93 | 8,08 | 7,86 | 8,05 | +2,38% | 2,83% | 150.361 |
| 18/06/2012 | 8,28 | 8,28 | 7,84 | 7,86 | -5,48% | 5,42% | 179.055 |
| 15/06/2012 | 8,22 | 8,33 | 8,08 | 8,32 | +0,68% | 2,96% | 176.971 |
| 14/06/2012 | 8,18 | 8,36 | 8,10 | 8,26 | +0,53% | 3,13% | 124.072 |
| 13/06/2012 | 8,06 | 8,35 | 8,00 | 8,22 | +2,17% | 4,34% | 170.880 |
| 12/06/2012 | 7,85 | 8,05 | 7,77 | 8,04 | +3,12% | 3,50% | 185.307 |
| 11/06/2012 | 8,38 | 8,38 | 7,67 | 7,80 | -5,37% | 8,41% | 319.959 |
| 08/06/2012 | 7,82 | 8,37 | 7,78 | 8,24 | +7,14% | 7,58% | 172.803 |
| 07/06/2012 | 7,82 | 7,89 | 7,67 | 7,69 | -0,40% | 2,79% | 87.844 |
| 06/06/2012 | 7,72 | 7,80 | 7,65 | 7,72 | +0,73% | 1,94% | 87.684 |
| 05/06/2012 | 7,65 | 7,81 | 7,48 | 7,67 | -0,73% | 4,32% | 153.247 |
| 04/06/2012 | 7,57 | 7,75 | 7,46 | 7,72 | +2,23% | 3,79% | 117.340 |
| 01/06/2012 | 7,67 | 7,77 | 7,47 | 7,55 | -3,35% | 3,98% | 152.926 |